[1] 中华人民共和国国家卫生和计划生育委员会.胎儿常见染色体异常与开放性神经管缺陷的产前筛查与诊断技术标准[S].北京:中国标准出版社,2010:1-9.
[2] ZHU Y,LU S,BIAN X,et al.A multicenter study of fetal chromosomal abnormalities in Chinese women of advanced maternal age[J].Taiwan J Obstet Gynecol,2016,55(3):379-384.
[3] BENN P,CUCKLE H.Theoretical performance of non-invasive prenatal testing for chromosome imbalances using counting of cell-free DNA fragments in maternal plasma[J].Prenat Diagn,2014,34(8):778-783.
[4] 王兰芳,章雪微,蒋慧芬.临海地区19770例孕中期产妇产前筛查结果的回顾性分析[J].中国优生与遗传杂志,2013,21(11):63-64.
[5] MANIKANDAN K,SESHADRI S.Down syndrome screening in india:are we there yet?[J].J Obstet Gynaecol India,2017,67(6):393-399.
[6] 赵晓曦,苏日娜,谷孝月,等.无创产前基因检测技术的临床应用价值[J].中华临床医师杂志(电子版),2013,7(23):10920-10922.
[7] 向萍霞,刘翎,冷培,等.游离胎儿DNA高通量基因测序技术在产前筛查的临床应用[J].实用妇产科杂志,2013,29(10):777-780.
[8] 靳继海,刘玉娟,王强.妊娠相关乳腺癌的临床和病理特点及预后的影响因素分析[J].东南大学学报(医学版),2018,37(3):82-86.
[9] 尤小燕,周芹,段晓峰.无创基因检测在唐氏综合征早期筛查中的应用[J].中国优生与遗传杂志,2014,22(10):45-46,43.
[10] MALONE F D,CANICK J A,BALL R H,et al.First-trimester or second-trimester screening, or both, for Down's syndrome[J].N Engl J Med,2005,353(19):2001-2011.
[11] VERWEIJ E J,JACOBSSON B,VAN SCHELTEMA P A,et al.European non-invasive trisomy evaluation (EU-NITE) study:a multicenter prospective cohort study for non-invasive fetal trisomy 21 testing[J].Prenat Diagn,2013,33(10):996-1001.
[12] 孙华,陈晓蓉.瞬时弹性成像在肝纤维化无创诊断中的临床应用[J].东南大学学报(医学版),2015,28(1):468-470.
[13] 谢小欢,麦慧映,曾晓凌.无创产前基因检测对唐氏综合征诊断准确性的影响研究[J].现代诊断与治疗,2017,28(10):1781-1782.
[14] PALOMAKI G E,KLOZA E M,LAMBERT-MESSERLIAN G M,et al.DNA sequencing of maternal plasma to detect Down syndrome:an international clinical validation study[J].Genet Med,2011,13(11):913-920. |